Skip to content

Clinical trials

Hepatitis, Chronic trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis, Chronic Country / region: United States Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20051
20061
20073
20083
20093
20101
20111
20122
20135
20141
20151
20161
20191
20222
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Terminated5
Recruiting3
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)7
Gilead Sciences4
Pfizer3
Bristol-Myers Squibb2
GlaxoSmithKline2
National Cancer Institute (NCI)2
Novartis Pharmaceuticals2
Pharmasset2
AusperBio Therapeutics Inc.1
Bachir Taouli1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis, Chronic33
Hepatitis C17
Hepatitis14
Liver Diseases14
Hepatitis C, Chronic10
Hepatitis, Viral, Human9
Hepatitis B8
Digestive System Diseases7
Virus Diseases7
Fibrosis5

Trials

Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.